1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Marcus & Millichap reported first-quarter 2025 revenue of $145.0 million, up 12.3% from a year earlier, and a net loss of $4.4 million, or $0.11 per diluted share, compared with a $10.0 million loss, or $0.26 per share, in the first quarter of 2024. The company said near-term market challenges are expected to extend through 2025, and it has not yet filed its quarterly report on Form 10-Q, so the results are preliminary. At its May 1 annual meeting, stockholders re-elected three directors and approved executive compensation, and the company will hold a say-on-pay vote every year.
Revenue rose to $145.0 million from $129.1 million; real estate brokerage commissions rose 12.9% to $123.6 million.
Net loss narrowed to $4.4 million ($0.11 per diluted share) from $10.0 million ($0.26 per diluted share).
Total operating expenses rose to $162.7 million from $149.2 million, and the operating loss narrowed to $17.7 million from $20.1 million.
At the May 1, 2025 annual meeting, George M. Marcus, George T. Shaheen and Don C. Watters were re-elected to terms ending in 2028, and Ernst & Young LLP was ratified as auditor for 2025.
LifeStance Health Group reported first-quarter 2025 revenue of $333.0 million, up 11% from $300.4 million a year earlier, and net income of $0.7 million compared with a net loss of $21.1 million in the prior-year quarter. The company reaffirmed its full-year 2025 guidance for revenue, Center Margin and Adjusted EBITDA, and gave second-quarter revenue guidance of $332 million to $352 million.
Q1 2025 revenue of $333.0 million, up 11%; Adjusted EBITDA of $34.6 million, up 25%
Net income of $0.7 million versus a net loss of $21.1 million in Q1 2024
Net cash used in operations was $3.1 million in Q1; cash ended the quarter at $134.3 million
Full-year 2025 guidance reiterated: revenue $1.40 billion to $1.44 billion; Adjusted EBITDA $130 million to $150 million
Avista Corp. reported first-quarter 2025 net income of $79 million, or $0.98 per diluted share, up from $71 million, or $0.91, a year earlier. The company confirmed its 2025 consolidated earnings guidance of $2.52 to $2.72 per diluted share. The results are in a press release dated May 7, 2025, furnished as Exhibit 99.1 to this 8-K.
Avista Utilities net income was $78 million, up from $67 million, with earnings of $0.97 per diluted share versus $0.86.
Electric utility margin increased by $28 million after tax, which the company attributed to general rate cases and customer growth.
2025 consolidated guidance of $2.52 to $2.72 per diluted share was confirmed, and the company expects new Oregon and Idaho rates to take effect in September if approved.
The company expects to issue $120 million of long-term debt and up to $80 million of common stock in 2025, including $16 million of stock issued in the first quarter.
Par Pacific reported a first-quarter 2025 net loss of $30.4 million, or $0.57 per diluted share, compared with a net loss of $3.8 million, or $0.06 per share, a year earlier. Adjusted EBITDA fell to $10.1 million from $94.7 million, and revenues declined to $1.745 billion from $1.981 billion, so headline results weakened sharply for shareholders even as the company repurchased $51 million of its stock.
Net loss of $30.4 million, or $0.57 per diluted share, versus a net loss of $3.8 million, or $0.06 per share, in Q1 2024
Adjusted EBITDA of $10.1 million, compared with $94.7 million in Q1 2024
Revenues of $1.745 billion, compared with $1.981 billion in Q1 2024
Repurchased $51 million of common stock, or 3.6 million shares, in Q1 2025; the Wyoming refinery had an operational incident on February 12, 2025 and returned to full operations in late April
VSE Corporation reported first-quarter 2025 revenue of $256.0 million, up 57.7%, and net income from continuing operations of $14.0 million, up 152.0%. The company still posted a net loss of $9.0 million, or $0.44 per diluted share, because of a $22.9 million loss from discontinued operations, and it reaffirmed its full-year 2025 Aviation revenue and Adjusted EBITDA margin guidance.
Revenue of $256.0 million, up 57.7%; diluted EPS from continuing operations of $0.67, up 91.4%
Net loss of $9.0 million, or $0.44 per diluted share, including a $22.9 million loss from discontinued operations
Full-year 2025 Aviation revenue growth guidance of 35% to 40% and Adjusted EBITDA margin of 16% to 17% reaffirmed
Net debt of $459 million at March 31, 2025; Fleet segment sale completed April 1, 2025 for up to $230 million
Berkshire Hathaway reported first-quarter 2025 net earnings of $4.6 billion, down from $12.7 billion a year earlier, as investment losses of $5.0 billion replaced prior-year investment gains of $1.5 billion. Operating earnings also declined, to $9.6 billion from $11.2 billion. At its May 3, 2025 annual meeting, shareholders voted on director elections and seven shareholder proposals, and each proposal drew far more Against votes than For votes.
Net earnings per average equivalent Class A share were $3,200 in Q1 2025 versus $8,825 in Q1 2024.
Operating earnings were $9.6 billion versus $11.2 billion; insurance-underwriting earnings were $1.3 billion versus $2.6 billion.
BNSF earnings rose to $1.2 billion from $1.1 billion, and Berkshire Hathaway Energy earnings rose to $1.1 billion from $717 million.
The company urged investors to read its 10-Q, which it said has been posted on its website.
Chord Energy reported first-quarter 2025 net income of $219.8 million, up from $199.4 million a year earlier, on total revenues of $1.2 billion. Diluted earnings per share fell to $3.66 from $4.65, and diluted weighted average shares rose to 59.7 million from 42.7 million. The company cut its 2025 E&P and other capital spending guidance by $30 million to about $1.37 billion, kept its 2025 production guidance, and said the macro outlook has deteriorated.
Net income was $219.8 million in the first quarter of 2025, compared with $199.4 million in the first quarter of 2024; diluted EPS was $3.66, compared with $4.65.
Total revenues were $1.2 billion ($1,215.0 million), compared with $1.1 billion ($1,085.3 million) a year earlier.
2025 E&P and other capital spending guidance was reduced by $30 million to about $1.37 billion; FY25 production guidance was maintained.
Declared a base dividend of $1.30 per share, payable June 9, 2025 to holders of record as of May 21, 2025; repurchased $216.5 million of common stock in the quarter.
Ovintiv reported a first-quarter 2025 net loss of $159 million, or $(0.61) per diluted share, compared with net earnings of $338 million a year earlier. The loss included a non-cash ceiling test impairment of $557 million after tax, while revenue rose slightly to $2,377 million and the company kept its full-year 2025 production and capital guidance. The filing also declared a $0.30 quarterly dividend.
Q1 2025 net loss of $159 million, or $(0.61) per diluted share, versus net earnings of $338 million in Q1 2024
Non-cash ceiling test impairment of $557 million after tax; pre-tax impairments were $730 million
Cash from operating activities of $873 million and Non-GAAP Free Cash Flow of $387 million
Quarterly dividend of $0.30 per share payable June 30, 2025, to holders of record June 13, 2025
Powell Industries reported fiscal 2025 second-quarter results for the period ended March 31, 2025, with revenue of $278.6 million, up 9%, and net income of $46.3 million, or $3.81 per diluted share, up 38% from a year earlier. The company also declared a quarterly cash dividend of $0.2675 per share, payable June 18, 2025, to shareholders of record on May 21, 2025.
Revenue of $278.6 million rose 9% from $255.1 million a year earlier; gross profit rose 33% to $83.4 million, or 29.9% of revenue.
Net income of $46.3 million, or $3.81 per diluted share, compared with $33.5 million, or $2.75 per diluted share, a year earlier.
Backlog was $1.3 billion as of March 31, 2025, essentially unchanged; new orders totaled $249 million.
Quarterly cash dividend of $0.2675 per share: record date May 21, 2025; payment date June 18, 2025.
Amentum reported results for the quarter ended March 28, 2025, with net income of $4 million compared with a loss of $41 million a year earlier. Pro forma revenue rose 1% to $3.49 billion and Adjusted EBITDA rose 3% to $268 million, while the company kept the midpoints of its fiscal 2025 guidance and narrowed its revenue range to $13.85 billion to $14.15 billion.
Q2 net income of $4 million, or $0.02 per diluted share, versus a loss of $41 million, or $0.46 per share, a year earlier
Pro forma revenue of $3,491 million, up 1%; Adjusted EBITDA of $268 million, up 3%; Adjusted diluted EPS of $0.53 versus $0.51
Fiscal 2025 guidance midpoints reaffirmed; revenue range narrowed to $13,850 million to $14,150 million from $13,800 million to $14,200 million
Free cash flow of $53 million in the quarter; backlog of $44.8 billion as of March 28, 2025
Coty reported fiscal third-quarter results for the period ended March 31, 2025, with reported net revenue of $1,299.1 million, down 6% from a year earlier, and a reported net loss of $409.0 million, compared with net income of $0.5 million in the prior year. The loss includes a $212.8 million asset impairment charge, mainly in Consumer Beauty's color cosmetics business. The company now expects fiscal 2025 EPS of $0.49-0.50, near the low end of its prior range, which matters to shareholders because it signals weaker earnings and a sales decline in the fourth quarter.
Q3 reported net revenue of $1,299.1 million fell 6%; on a like-for-like basis, sales fell 3%.
Q3 reported net loss of $409.0 million, or $(0.47) per diluted share, versus net income of $0.5 million a year earlier; includes a $212.8 million asset impairment charge.
Fiscal 2025 EPS expected at $0.49-0.50, near the low end of prior guidance; free cash flow expected at approximately $300 million.
Fourth-quarter like-for-like sales expected to decline by a high single-digit percentage.
Chemours reported a first-quarter 2025 net loss of $4 million, or $0.03 per diluted share, compared with net income of $54 million a year earlier. Adjusted EBITDA fell 13% to $166 million, mainly on lower pricing, and the company cut its quarterly dividend 65% to $0.0875 per share. For shareholders, the lower dividend reduces cash returned to them, and the company's 2025 adjusted EBITDA outlook of $825 million to $950 million is the main guide to near-term earnings.
Net sales were $1.4 billion ($1,368 million), flat year over year; net loss was $4 million versus net income of $54 million in Q1 2024.
Adjusted net income was $19 million, or $0.13 per diluted share, versus $47 million, or $0.31, a year earlier.
Restructuring charges of $27 million were tied to the exit of the SPS Capstone business, which the company expects to end by the end of the second quarter of 2025.
Quarterly dividend cut 65% to $0.0875 per share for the second quarter, payable June 16, 2025; full-year 2025 adjusted EBITDA outlook is $825 million to $950 million.
Innovex reported first-quarter 2025 revenue of $240 million, down 4% from the prior quarter, with net income of $15 million and Adjusted EBITDA of $46 million. For the second quarter, the company guided to revenue of $225 million to $235 million and Adjusted EBITDA of $40 million to $45 million, both below first-quarter levels, citing softness in Mexico and slight activity declines in the North American land market.
Q1 2025 revenue of $240 million, down 4% quarter over quarter; net income of $15 million; Adjusted EBITDA of $46 million
Q2 2025 guidance: total revenue of $225 million to $235 million and Adjusted EBITDA of $40 million to $45 million
Agreed to sell the legacy Dril-Quip Eldridge facility for $95 million; the company also has a $100 million share repurchase program
As of May 5, 2025, repurchased 395,234 shares at an average price of $14.94
Protagonist Therapeutics reported a first-quarter 2025 net loss of $11.7 million, or $0.19 per share, compared with net income of $207.3 million, or $3.41 per basic share, in the first quarter of 2024. License and collaboration revenue fell to $28.3 million from $255.0 million, as the prior-year period included most of the Takeda upfront payment. Cash, cash equivalents and marketable securities rose to $697.9 million, which the company expects to fund operations through at least the end of 2028.
License and collaboration revenue was $28.3 million, versus $255.0 million in Q1 2024; $22.8 million reflects a $25 million milestone earned in Q1 2025 but payable after the VERIFY clinical study report.
Net loss was $11.7 million, or $0.19 per basic and diluted share, compared with net income of $207.3 million in Q1 2024.
Cash, cash equivalents and marketable securities were $697.9 million at March 31, 2025, up from $559.2 million at December 31, 2024.
Rusfertide Phase 3 VERIFY data is scheduled for an oral presentation at the ASCO plenary session on June 1, 2025.
Lumentum reported fiscal third-quarter 2025 results for the quarter ended March 29, 2025, with net revenue up 16.0% year over year to $425.2 million. The GAAP net loss narrowed to $44.1 million, or $0.64 per diluted share, from $127.0 million, or $1.88 per share, a year earlier. The company also gave fiscal fourth-quarter guidance of $440 million to $470 million in net revenue and non-GAAP diluted EPS of $0.70 to $0.80.
Net revenue was $425.2 million, up 5.7% from $402.2 million in the prior quarter and up 16.0% from $366.5 million a year earlier.
GAAP net loss was $44.1 million ($0.64 per diluted share), compared with a net loss of $60.9 million in the prior quarter and $127.0 million a year earlier.
Non-GAAP diluted EPS was $0.57, compared with $0.42 in the prior quarter and $0.09 a year earlier.
Q4 fiscal 2025 guidance: net revenue of $440 million to $470 million and non-GAAP diluted EPS of $0.70 to $0.80; cash and short-term investments were $866.7 million at quarter end.
Horace Mann reported first-quarter 2025 net income of $38.2 million, or $0.92 per diluted share, up from $26.5 million, or $0.64, a year earlier, on total revenues of $416.4 million, up 7.9%. The company also updated its full-year 2025 core earnings per share guidance to $3.85 to $4.15 to reflect a change in its core earnings definition, and appointed Maureen Temchuk as Controller and Chief Accounting Officer effective May 5, 2025.
Net income was $38.2 million, or $0.92 per diluted share, versus $26.5 million, or $0.64, in the first quarter of 2024.
Total revenues were $416.4 million, up 7.9% from $386.0 million.
Core earnings were $44.7 million, or $1.07 per diluted share, versus $25.8 million, or $0.62, a year earlier (non-GAAP).
Full-year 2025 core EPS guidance is $3.85 to $4.15, updated to reflect a change in the core earnings definition; Maureen Temchuk was appointed Controller and Chief Accounting Officer on May 5, 2025.
Voya Financial reported first-quarter 2025 results on May 6, 2025. Net income available to common shareholders fell to $139 million, or $1.42 per diluted share, from $234 million, or $2.24, a year earlier, while adjusted operating earnings rose to $195 million, or $2.00 per diluted share, from $185 million, or $1.77. For shareholders, the picture is mixed: the adjusted measure improved mainly due to the OneAmerica acquisition, but reported profit and total revenues declined.
Net income available to common shareholders was $139 million, or $1.42 per diluted share, versus $234 million, or $2.24, in first-quarter 2024.
Adjusted operating earnings were $195 million, or $2.00 per diluted share, versus $185 million, or $1.77; the filing cites the OneAmerica acquisition as the main driver.
Total revenues were $1,969 million versus $2,051 million, as the prior period included net investment gains that did not repeat.
Health Solutions adjusted operating earnings were $46 million, down from $59 million, and its trailing twelve-month adjusted operating margin fell to 2.7% from 23.9%.
IFF reported a first-quarter 2025 GAAP loss before taxes of $994 million and a diluted loss of $3.98 per share, driven by a $1.15 billion goodwill impairment in Food Ingredients. Reported net sales fell 2% to $2.84 billion, while adjusted EPS excluding amortization was $1.20 and the company kept its full-year 2025 guidance ranges unchanged.
Reported net sales were $2.84 billion, down 2% from the prior-year period; comparable currency neutral sales rose 3%.
Reported diluted EPS was $(3.98), versus $0.23 a year earlier; adjusted EPS excluding amortization was $1.20, versus $1.13 in the prior-year period.
Adjusted operating EBITDA was $578 million; the company maintained full-year 2025 sales guidance of $10.6 billion to $10.9 billion.
The Pharma Solutions divestiture closed on May 1, 2025, earlier than anticipated.
Arcosa reported first quarter 2025 revenue of $632.0 million, up 6% from a year earlier, and Adjusted EBITDA of $109.9 million, up 19%. GAAP net income fell 40% to $23.6 million, or $0.48 per diluted share, and free cash flow was negative $29.7 million. The company reaffirmed its full-year 2025 revenue guidance of $2.8 billion to $3.0 billion and Adjusted EBITDA guidance of $545 million to $595 million, so the outlook is unchanged even though GAAP earnings and cash flow weakened.
Revenue was $632.0 million, up 6% from $598.6 million, or 12% excluding the divested steel components business.
Adjusted EBITDA was $109.9 million, up 19% from $92.0 million; net income was $23.6 million versus $39.2 million.
Diluted EPS was $0.48 versus $0.80; adjusted diluted EPS was $0.49 versus $0.73.
Full-year 2025 guidance reaffirmed: revenue of $2.8 billion to $3.0 billion and Adjusted EBITDA of $545 million to $595 million.
Assurant reported first-quarter 2025 GAAP net income of $146.6 million, down 38% from a year earlier, after $157.0 million of reportable catastrophes, mainly California wildfires. Excluding catastrophes, adjusted earnings per diluted share rose 16% to $5.79, and the company reaffirmed its 2025 outlook for modest growth.
GAAP net income was $146.6 million versus $236.4 million in Q1 2024; diluted EPS was $2.83 versus $4.47.
Reportable catastrophes were $157.0 million pre-tax versus $13.0 million; about $125 million was from the California wildfires, including estimated subrogation recoveries.
Adjusted earnings per diluted share excluding catastrophes rose 16% to $5.79 from $4.97.
Holding company liquidity was $501 million at March 31, 2025; the company repurchased $25 million of shares from April 1 through May 2, 2025.
Safehold reported first-quarter 2025 results for the period ended March 31, 2025. Revenue rose 5% year over year to $97.7 million, but GAAP net income attributable to common shareholders fell 4% to $29.4 million, or $0.41 per share, from $0.43 a year earlier, after a $1.9 million non-recurring loss from writing off a preferred equity position in a leasehold joint venture. Excluding that loss, EPS was $0.44, up about $0.01.
Q1 2025 revenue: $97.7 million, up from $93.2 million in Q1 2024 (up 5%).
GAAP EPS: $0.41 versus $0.43 a year earlier (down 5%); net income attributable to common shareholders was $29.4 million versus $30.7 million.
Excluding a $1.9 million non-recurring loss, EPS was $0.44 versus $0.43 (up 1%).
Filing states Q1 2025 is as of March 31, 2025; the earnings release and presentation are furnished as Exhibits 99.1 and 99.2 and are not deemed filed under Section 18.
The Andersons reported first quarter 2025 results, with net income attributable to the company falling to $0.3 million, or $0.01 per diluted share, from $5.6 million, or $0.16, a year earlier. Sales and merchandising revenues declined to $2.66 billion from $2.72 billion, and adjusted EBITDA rose to $57 million from $51 million, driven by Renewables. For shareholders, the headline profit measures weakened, and the company used $350 million of cash in operations during the quarter.
Net income attributable to The Andersons was $0.3 million, or $0.01 per diluted share, versus $5.6 million, or $0.16, in Q1 2024.
Adjusted diluted EPS was $0.12, compared with $0.16 a year earlier.
Agribusiness recorded a pretax loss of $10 million; Renewables reported pretax income of $25 million.
Cash used in operating activities was $350 million, compared with $240 million in the first quarter of 2024.
Devon Energy reported first-quarter 2025 net earnings of $494 million, or $0.77 per diluted share, down from $596 million, or $0.94, a year earlier, while core earnings were $779 million, or $1.21 per share. The company raised its full-year 2025 oil production forecast and cut its full-year capital guidance by $100 million to $3.7 billion to $3.9 billion, which may matter to shareholders because it shows output above plan alongside lower spending.
Net earnings were $494 million ($0.77 per diluted share) versus $596 million ($0.94) in Q1 2024, and $639 million ($0.98) in Q4 2024; a $254 million asset impairment from divesting two corporate real estate assets weighed on results.
Oil production averaged 388,000 barrels per day, exceeding guidance by 5,000 barrels per day; full-year 2025 oil forecast raised to 382,000 to 388,000 barrels per day.
Full-year 2025 capital guidance cut to $3.7 billion to $3.9 billion from about $3.9 billion; first-quarter capital spending was $964 million, 5% below midpoint guidance.
Devon agreed on May 5, 2025 to sell its equity interest in the Matterhorn Pipeline for approximately $375 million, expected to close in the second quarter of 2025; the company declared a $0.24 per share quarterly dividend payable June 30, 2
Bristow Group reported first quarter 2025 revenue of $350.5 million, down from $353.5 million in the fourth quarter of 2024, and net income attributable to the company of $27.4 million, or $0.92 per diluted share, versus $31.8 million, or $1.07 per diluted share, in the prior quarter. The company affirmed its 2025 Adjusted EBITDA outlook of $230 million to $260 million and its 2026 outlook of $275 million to $335 million, so guidance was not changed.
Q1 2025 total revenues were $350.5 million, compared with $353.5 million in Q4 2024.
Net income attributable to Bristow Group was $27.4 million, or $0.92 per diluted share, compared with $31.8 million, or $1.07 per diluted share, in Q4 2024.
Adjusted EBITDA was $57.7 million, consistent with $57.8 million in Q4 2024.
Net cash used in operating activities was $0.6 million; working capital used $56.4 million of cash in the quarter. As of March 31, 2025, total liquidity was $254.3 million.
Fortune Brands reported first quarter 2025 net sales of $1.0 billion, down 7% from a year earlier, and GAAP diluted EPS of $0.42, down 45%. EPS before charges and gains fell 20% to $0.66, and the company is not providing detailed full-year 2025 guidance, instead outlining an EPS framework for different volume scenarios on its earnings call.
Q1 2025 net sales were $1,033.1 million, down 7%; organic sales excluding China and FX fell 5%
GAAP diluted EPS was $0.42 versus $0.76; EPS before charges/gains was $0.66 versus $0.83, down 20%
Operating income was $97.0 million, down 38%; restructuring charges totaled $24.8 million
Company repurchased $175 million of shares in the quarter and had net debt of $2.6 billion at March 29, 2025
Vestis reported fiscal second-quarter 2025 revenue of $665 million, down $40.1 million from a year earlier, and a net loss of $27.8 million, compared with net income of $6.0 million in the prior-year quarter. The company also amended its credit agreement to raise its net leverage covenant to 5.25x through fiscal 2026, and it eliminated its dividend, with dividends and share repurchases restricted under the amendment.
Revenue of $665 million, down $40.1 million year over year; net loss of $27.8 million, or $(0.21) per diluted share, versus net income of $6.0 million, or $0.05 per diluted share, a year earlier
Adjusted EBITDA of $47.6 million, including a one-time $15.0 million bad debt expense; $62.6 million excluding it, or 9.4% of revenue, versus $87.2 million in the prior-year quarter
Net leverage covenant raised from 4.50x to 5.25x through the second quarter of fiscal 2026; net leverage was 4.16x at quarter end
Third-quarter fiscal 2025 revenue guidance of $674 million to $682 million and Adjusted EBITDA of at least $63 million; Jim Barber named CEO effective June 2, 2025
United Fire Group reported first quarter 2025 results, with net income up 31% to $17.7 million ($0.67 per diluted share) and net written premium up 4% to a record $335.4 million. The combined ratio rose 0.5 points to 99.4%, mainly due to a higher underwriting expense ratio, while the underlying loss ratio improved.
Net income rose 31% to $17.7 million ($0.67 per diluted share) from $13.5 million in the first quarter of 2024.
Adjusted operating income rose 27% to $18.3 million ($0.70 per diluted share).
The combined ratio rose 0.5 points to 99.4%; the underwriting expense ratio rose 3.0 points to 37.9%, mainly from non-recurring costs tied to a new policy administration system.
Book value per share was $32.13 as of March 31, 2025, up from $30.80 at December 31, 2024.
Douglas Emmett reported first-quarter 2025 results, with revenues of $252 million, up from $245 million a year earlier, and net income attributable to common stockholders of $40 million, up from $9 million. Funds from operations (FFO) per fully diluted share fell to $0.40 from $0.45, and adjusted FFO (AFFO) fell to $62 million from $75 million. The company also gave 2025 guidance of $0.07 to $0.13 in diluted net income per share and $1.42 to $1.48 in FFO per fully diluted share.
Total revenues were $252 million for the quarter ended March 31, 2025, versus $245 million in Q1 2024.
Net income attributable to common stockholders was $40 million, or $0.24 per basic and diluted share, compared with $9 million a year earlier; the filing cites a $47.2 million gain from consolidating a joint venture.
FFO per fully diluted share was $0.40 versus $0.45, and AFFO was $62 million versus $75 million.
2025 guidance: net income per diluted share of $0.07 to $0.13 and FFO per fully diluted share of $1.42 to $1.48.
Arcus Biosciences reported first-quarter 2025 revenue of $28 million, down from $145 million a year earlier, and a net loss of $112 million, compared with $4 million in the same period of 2024. The company said it expects GAAP revenue of $75 million to $90 million for full-year 2025, and it ended the quarter with $1.0 billion in cash, cash equivalents and marketable securities.
Revenue was $28 million versus $145 million a year earlier; license and development services revenue was $20 million versus $135 million.
Net loss was $112 million, or $1.14 per share, versus a net loss of $4 million, or $0.05 per share, in the first quarter of 2024.
R&D expenses rose to $122 million from $109 million, driven by early-stage and preclinical program activity.
Full-year 2025 GAAP revenue is expected to be between $75 million and $90 million.
Gulfport Energy reported a first-quarter 2025 net loss of $0.5 million, or $0.07 per diluted share, compared with net income of $52.0 million, or $2.34 per diluted share, a year earlier. A $146.5 million net loss on derivatives cut total revenues to $197.0 million from $283.2 million, and the company reaffirmed its full-year 2025 guidance and said it plans to return substantially all adjusted free cash flow, excluding discretionary acreage acquisitions, through share repurchases.
Net loss of $464 thousand, or $0.07 per diluted share, versus net income of $52.0 million, or $2.34 per diluted share, in Q1 2024.
Total revenues were $197.0 million versus $283.2 million, after a $146.5 million net loss on derivatives compared with a $45.1 million gain a year earlier.
Adjusted EBITDA was $218.3 million and adjusted free cash flow was $36.6 million; the company repurchased about 340.7 thousand shares for $60.0 million.
Full-year 2025 guidance was reaffirmed; natural gas production is expected to rise about 20% by fourth quarter 2025 versus Q1 2025, and late-2025 drilling will shift toward dry gas Utica development.
Jazz reported first-quarter 2025 total revenues of $897.8 million, roughly flat with $902.0 million a year earlier, and a GAAP net loss of $92.5 million, or $1.52 per share, versus a $14.6 million loss in the prior-year quarter. The loss reflects a $172.0 million expense for Xyrem antitrust litigation settlements, and the company cut its 2025 profit guidance while affirming its revenue range of $4.15 billion to $4.40 billion.
Q1 2025 non-GAAP adjusted net income was $105.2 million, or $1.68 per diluted share, down from $178.4 million, or $2.63, in Q1 2024.
2025 GAAP net loss guidance is now $(615) million to $(450) million, versus prior net income guidance of $560 million to $720 million.
2025 non-GAAP adjusted net income guidance is now $250 million to $350 million, versus prior guidance of $1.4 billion to $1.5 billion.
The guidance change reflects the April 2025 Chimerix acquisition, which the company completed for approximately $935 million in cash.
Qualys reported first-quarter 2025 revenue of $159.9 million, up 10% from a year earlier, and GAAP net income of $47.5 million, or $1.29 per diluted share, up from $1.05. The company raised its full-year 2025 revenue and per-share earnings guidance, which is a positive signal for shareholders, though the filing notes that reconciling items are likely to significantly affect GAAP earnings.
Q1 2025 revenue was $159.9 million, up 10% from $145.8 million in Q1 2024.
GAAP diluted EPS was $1.29 vs. $1.05 a year earlier; non-GAAP diluted EPS was $1.67 vs. $1.45.
Full-year 2025 revenue guidance is $648.0 million to $657.0 million, up from a prior range of $645.0 million to $657.0 million.
Full-year 2025 GAAP EPS guidance is $4.27 to $4.57, up from $3.62 to $4.02; non-GAAP EPS guidance is $6.00 to $6.30, up from $5.50 to $5.90.
MasterBrand reported first quarter 2025 results for the period ended March 30, 2025. Net sales rose 3% to $660.3 million, helped by the Supreme acquisition, but net income fell 65% to $13.3 million and diluted earnings per share were $0.10, compared with $0.29 a year earlier. The company revised its 2025 outlook, citing weaker end-market demand and the net impact of enacted tariffs, which matters to shareholders because profit is falling while the guidance points to lower full-year results.
Net sales rose 3% to $660.3 million, including 10% growth from Supreme, while base business volume fell 9%.
Net income fell to $13.3 million from $37.5 million; adjusted diluted EPS was $0.18 versus $0.31.
2025 guidance: net sales down a low single-digit percentage; adjusted EBITDA of $315 million to $365 million; adjusted diluted EPS of $1.03 to $1.32.
Free cash flow was negative $41.2 million for the quarter, and the company repurchased about $11.4 million of stock.
Teradata reported first-quarter 2025 results with total revenue down 10% to $418 million from $465 million, while GAAP diluted EPS rose to $0.45 from $0.20. The company increased its full-year 2025 GAAP diluted EPS outlook to $1.06 to $1.16 and kept its non-GAAP EPS outlook of $2.15 to $2.25, while total revenue guidance for 2025 was updated and second-quarter total revenue is expected to fall 7% to 9%.
Total revenue was $418 million, down 10% as reported and 8% in constant currency, versus $465 million a year earlier.
GAAP diluted EPS was $0.45 versus $0.20; non-GAAP diluted EPS was $0.66 versus $0.57.
Public cloud ARR rose 15% to $606 million, while total ARR fell 3% to $1.442 billion.
Full-year 2025 GAAP diluted EPS outlook was raised to $1.06 to $1.16; Q2 2025 total revenue is expected to decline 7% to 9% year over year in constant currency.
Mercury General reported a first-quarter 2025 net loss of $108.3 million, or $1.96 per diluted share, compared with net income of $73.5 million, or $1.33 per share, a year earlier. The company cited $447 million in catastrophe losses, mostly from the January 2025 Southern California wildfires, which pushed its combined ratio to 119.2% from 100.9%.
Net loss of $108.3 million ($1.96 per diluted share) versus net income of $73.5 million ($1.33) in Q1 2024
Catastrophe losses net of reinsurance were $447 million, versus $72 million a year earlier
Net premiums earned rose 10.0% to $1.28 billion, while the combined ratio rose to 119.2%
Board declared a quarterly dividend of $0.3175 per share, payable June 26, 2025
Astera Labs reported first-quarter 2025 results for the period ended March 31, 2025, with revenue of $159.4 million, up 13% from the prior quarter and 144% from a year earlier. GAAP net income was $31.8 million, or $0.18 per diluted share, compared with a net loss of $93.0 million a year earlier. The company also guided second-quarter revenue to $170 million to $175 million, which would extend growth for shareholders if achieved.
Q1 2025 revenue of $159.4 million, up 13% sequentially and 144% year-over-year
GAAP net income of $31.8 million and diluted EPS of $0.18, versus a net loss of $93.0 million and EPS of $(1.77) in Q1 2024
Non-GAAP diluted EPS of $0.33 for Q1 2025
Q2 2025 outlook: revenue of $170 million to $175 million; GAAP diluted EPS of $0.10 to $0.11
BlackLine reported first quarter 2025 results for the period ended March 31, 2025, with GAAP revenue up 6% to $166.9 million. GAAP net income attributable to BlackLine fell to $6.1 million, or $0.10 per diluted share, from $10.8 million, or $0.17, a year earlier, and free cash flow fell to $32.6 million from $43.7 million. The company also gave second quarter and full year 2025 revenue ranges of $170 million to $172 million and $692 million to $705 million.
Q1 2025 GAAP revenue of $166.9 million, up 6% from $157.5 million in Q1 2024
GAAP net income attributable to BlackLine of $6.1 million ($0.10 per diluted share) vs. $10.8 million ($0.17) a year earlier; restructuring costs were $5.3 million vs. $0.4 million
Non-GAAP net income of $36.3 million ($0.49 per diluted share) vs. $40.1 million ($0.54); free cash flow of $32.6 million vs. $43.7 million
Full year 2025 GAAP revenue guidance of $692 million to $705 million; Q2 2025 GAAP revenue guidance of $170 million to $172 million
Grocery Outlet reported first quarter fiscal 2025 results, with net sales up 8.5% to $1.13 billion but a net loss of $23.3 million, compared with a $1.0 million loss a year earlier. The company cut its fiscal 2025 comparable store sales guidance to 1.0% to 2.0% from 2.0% to 3.0%, and it also disclosed the upcoming departures of two executive officers.
Net sales rose 8.5% to $1.13 billion; comparable store sales rose 0.3%.
Net loss was $23.3 million, or $(0.24) per diluted share, including $33.9 million in restructuring charges; adjusted earnings per share were $0.13 versus $0.09 a year earlier.
Fiscal 2025 comparable store sales guidance was cut to 1.0% to 2.0%; net sales, adjusted EBITDA and adjusted earnings per share guidance were maintained.
Ramesh Chikkala, EVP and Chief Operations Officer, is expected to depart on or around June 6, 2025; Pamela B. Burke, EVP and Chief Stores Officer, on or around October 6, 2025.
Gen Digital reported GAAP results for fiscal 2025, which ended March 28, 2025, with revenue of $3,935 million, up 4%, and diluted EPS of $1.03, up 9%. The company guided fiscal 2026 non-GAAP revenue to $4,700 million to $4,800 million and EPS to $2.46 to $2.54, and its board approved a $0.125 quarterly dividend. Shareholders get a clear view of growth and the outlook, though results include a $66 million legal contract dispute charge.
Fiscal 2025 GAAP revenue was $3,935 million, up 4%, and GAAP operating income was $1,610 million, up 45%.
Fiscal 2026 guidance: revenue of $4,700 million to $4,800 million and non-GAAP EPS of $2.46 to $2.54.
Q4 fiscal 2025 GAAP revenue was $1,010 million, up 5%, and diluted EPS was $0.23, up 11%.
Quarterly dividend of $0.125 per share is payable June 11, 2025, to holders of record on May 19, 2025.
Grand Canyon Education reported first quarter 2025 results on May 6, 2025. Service revenue rose 5.3% to $289.3 million and diluted EPS rose to $2.52 from $2.29, while operating margin slipped to 30.4% from 30.8%. The company also issued quarterly and full-year 2025 outlooks, with full-year diluted EPS guidance of $8.36 to $8.70.
Service revenue of $289.3 million, up 5.3% from $274.7 million; partner enrollments rose 5.8% to 127,779.
Net income of $71.6 million, up 5.3%; diluted EPS of $2.52 vs. $2.29 (as adjusted $2.57 vs. $2.35).
Operating income of $88.0 million, up 4.2%; operating margin 30.4% vs. 30.8%.
Full-year 2025 outlook: service revenue of $1,079.8 million to $1,099.8 million; diluted EPS of $8.36 to $8.70.
Kulicke & Soffa reported fiscal second-quarter 2025 results for the period ended March 29, 2025. Net revenue fell 5.9% year over year to $162.0 million, and GAAP net loss was $84.5 million, or $(1.59) per diluted share, driven largely by about $86.6 million in pre-tax charges tied to its planned cessation of the Electronics Assembly equipment business. The company expects third-quarter revenue of about $145 million, plus or minus $10 million, and a GAAP diluted loss of about $(0.09) per share.
Net revenue of $162.0 million, down 5.9% from $172.1 million in the prior-year quarter; GAAP net loss of $84.5 million narrowed from $102.7 million a year earlier.
Non-GAAP net loss of $27.9 million, or $(0.52) per diluted share, versus GAAP $(1.59).
Pre-tax charges of about $86.6 million related to the intended cessation of the Electronics Assembly equipment business, announced March 31, 2025.
Third-quarter fiscal 2025 outlook: net revenue about $145 million plus or minus $10 million; GAAP diluted EPS about $(0.09); non-GAAP diluted EPS about $0.05.
eXp World Holdings reported first-quarter 2025 revenue of $954.9 million, up 1% from a year earlier, and a net loss of $11.0 million, narrower than the $15.6 million net loss in the first quarter of 2024. Agent and broker count and transaction volume declined, and the company's board declared a $0.05 per share quarterly cash dividend.
Revenue rose 1% to $954.9 million; net loss was $11.0 million, or $(0.07) per diluted share, versus $(0.10) a year earlier.
Adjusted EBITDA, a non-GAAP measure, was $2.2 million, down from $11.0 million in the first quarter of 2024.
Agents and brokers fell 5% to 81,904 and real estate sales transactions fell 2% to 89,643, while sales volume rose 4% to $38.6 billion.
The $0.05 dividend is payable June 4, 2025 to holders of record May 19, 2025 per the press release; the Item 7.01 text gives May 30 and May 12 instead.
Cytokinetics reported first quarter 2025 results, with revenue of $1.6 million, up from $0.8 million a year earlier, but a net loss of $161.4 million, or $(1.36) per share, versus a $135.6 million loss, or $(1.33) per share, in the first quarter of 2024. The FDA extended the review target date for aficamten in obstructive HCM to December 26, 2025, and the company maintained its full-year 2025 GAAP operating expense guidance of $670 million to $710 million.
Q1 2025 revenue was $1.6 million, compared with $0.8 million in Q1 2024.
Q1 2025 net loss was $161.4 million, or $(1.36) per share, compared with $135.6 million, or $(1.33) per share, a year earlier.
R&D expenses rose to $99.8 million from $81.6 million, and G&A expenses rose to $57.4 million from $45.5 million.
The FDA extended the aficamten PDUFA date to December 26, 2025; cash, cash equivalents and investments were about $1.1 billion at March 31, 2025.
Corsair reported first-quarter 2025 net revenue of $369.8 million, up from $337.3 million a year earlier, and a net loss attributable to common shareholders of $10.1 million, or $0.10 per diluted share, compared with a loss of $0.12 per share a year earlier. The company did not reaffirm its full-year 2025 guidance because of uncertainty from newly announced tariffs, though it said it remains on track to meet the February 12, 2025 guidance if current conditions hold.
Net revenue was $369.8 million versus $337.3 million in Q1 2024; Gaming Components and Systems segment revenue was $257.8 million.
Adjusted EBITDA was $22.6 million versus $18.0 million; total gross margin was 27.7% versus 25.7%.
Full-year 2025 guidance was not reaffirmed; Corsair intends to provide an updated outlook later this year.
Cash and restricted cash was $102.5 million as of March 31, 2025.
Wynn Resorts reported first-quarter 2025 operating revenues of $1.70 billion, down $162.5 million from a year earlier, and net income attributable to the company of $72.7 million, down from $144.2 million. Diluted earnings per share were $0.69, compared with $1.30 in the first quarter of 2024, and the company's board declared a $0.25 per share cash dividend.
Operating revenues were $1.70 billion, down $162.5 million from $1.86 billion in Q1 2024.
Diluted net income per share was $0.69, versus $1.30 a year earlier; adjusted net income per diluted share was $1.07, versus $1.59.
Adjusted Property EBITDAR was $532.9 million, down from $646.5 million, with Wynn Palace and Wynn Macau among the largest declines.
Cash dividend of $0.25 per share is payable May 30, 2025 to holders of record as of May 16, 2025; the company repurchased $200.0 million of stock in the quarter.
PTC Therapeutics reported first quarter 2025 results, with total revenue of $1,176.1 million and net income of $866.6 million, compared with a net loss of $91.6 million a year earlier. The results were driven by a $986.2 million license and collaboration payment from Novartis for PTC518, while net product and royalty revenue fell to $189.9 million from $208.8 million. The company narrowed its full-year 2025 revenue guidance to $650 million to $800 million.
Total revenue was $1,176.1 million, versus $210.1 million in the first quarter of 2024, including $986.2 million tied to the PTC518 license with Novartis, which closed in January 2025.
Net product and royalty revenue was $189.9 million, down from $208.8 million a year earlier.
Net income was $866.6 million, or $10.04 per diluted share, compared with a net loss of $91.6 million, or $1.20 per share, in the first quarter of 2024.
Full-year 2025 revenue guidance was narrowed to $650 million to $800 million; cash and marketable securities were $2,027.2 million as of March 31, 2025.
Cirrus Logic reported fourth-quarter fiscal 2025 revenue of $424.5 million and full-year revenue of $1.90 billion, up six percent, with full-year GAAP diluted EPS of $6.00, a record. The company guided first-quarter fiscal 2026 revenue to $330 million to $390 million, down 15 percent sequentially at the midpoint, and disclosed a $500 million buyback authorization approved in March 2025.
Q4 FY25 revenue was $424.5 million, down 24 percent from Q3 FY25 and up 14 percent from Q4 FY24; GAAP diluted EPS was $1.31.
FY25 GAAP diluted EPS was $6.00 versus $4.90 in FY24; non-GAAP diluted EPS was $7.54 versus $6.59.
Q1 FY26 revenue is expected between $330 million and $390 million, with GAAP gross margin of 51 percent to 53 percent.
The Board authorized up to $500 million in share repurchases in March 2025; $54 million remained under the July 2022 authorization at fiscal year-end, and $25 million was used after quarter-end under a 10b5-1 plan.
Mercury Systems reported third-quarter fiscal 2025 results for the period ended March 28, 2025. Revenue rose to $211.4 million from $208.3 million a year earlier, and the GAAP net loss narrowed to $19.2 million from $44.6 million, while adjusted EPS moved to $0.06 from a loss of $0.26 per share.
Revenue was $211.4 million, compared with $208.3 million in the third quarter of fiscal 2024.
GAAP net loss was $19.2 million, or $0.33 per share, versus $44.6 million, or $0.77 per share, a year earlier.
Adjusted EPS was $0.06 versus $(0.26), and adjusted EBITDA was $24.7 million versus $(2.4) million.
Free cash flow was $24.1 million versus $(25.7) million; bookings were $200.4 million, with a quarterly book-to-bill ratio of 0.95.
Expeditors International reported first quarter 2025 results with diluted EPS up 26% to $1.47, net earnings attributable to shareholders up 20% to $204 million, and revenues up 21% to $2.7 billion compared with the same quarter of 2024. Management said early signs point to a significant decline in China to U.S. ocean volumes after March 31, 2025, and that the outlook for air capacity and rates remains volatile.
Diluted EPS of $1.47 versus $1.17 a year earlier, up 26%
Operating income of $266 million, up 24%; revenues of $2.7 billion, up 21%
Company generated $343 million in operating cash flow and repurchased $177 million of stock
Management said it is too early to know the overall decline in China to U.S. ocean volumes that began after March 31, 2025
XPEL reported first-quarter 2025 revenue of $103.8 million, up 15.2%, and net income of $8.6 million, up 28.8%, with EPS of $0.31 versus $0.24. The board authorized a stock repurchase of up to $50 million, and the company expects second-quarter 2025 revenue of approximately $117 million to $119 million. The results are preliminary and unaudited until the Form 10-Q, expected on or before May 9, 2025.
Revenue rose 15.2% to $103.8 million; net income rose 28.8% to $8.6 million
Diluted EPS was $0.31 versus $0.24 in the first quarter of 2024
Board authorized repurchases of up to $50 million of common stock
Company expects second-quarter 2025 revenue of approximately $117 million to $119 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.